Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the GRHL2 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
The limited documentation surrounding autosomal dominant nonsyndromic hearing loss 28 is primarily due to its rarity and the recent identification of the GRHL2 gene's role in the condition. As it affects a small number of individuals, comprehensive clinical studies and systematic documentation have been challenging to conduct. This can lead to feelings of isolation for patients and families seeking more information.
To navigate your journey with autosomal dominant nonsyndromic hearing loss 28, consider seeking a geneticist or an audiologist with experience in hereditary hearing loss. Genetic counseling can provide valuable insights into the implications of the GRHL2 mutation for you and your family. While there are no specific patient organizations identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer helpful information and support. Additionally, inquire about participating in any relevant clinical trials for further insights into your condition.
Currently, there are no orphan drug designations for autosomal dominant nonsyndromic hearing loss 28. However, there is one active clinical trial related to this condition. For more details, you can explore the available studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=autosomal%20dominant%20nonsyndromic%20hearing%20loss%2028.
Actionable guidance for navigating care for autosomal dominant nonsyndromic hearing loss 28
To navigate your journey with autosomal dominant nonsyndromic hearing loss 28, consider seeking a geneticist or an audiologist with experience in hereditary hearing loss. Genetic counseling can provide valuable insights into the implications of the GRHL2 mutation for you and your family. While there are no specific patient organizations identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer helpful information and support. Additionally, inquire about participating in any relevant clinical trials for further insights into your condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.